BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025
• 2026

Month

• January
• February
• March

Day

• 1
• 2
• 3
• 4
• 5
• 6

• Press Releases

  Gyre Therapeutics Enters into Agreement to Acquire Cullgen to Gain Targeted Protein Degradation Platform and Pipeline

  March 2, 2026

   · 

  10 min read
• Press Releases

  Monopar Expands Leadership Team with Appointment of Seasoned Biopharma Executive Susan Rodriguez as Chief Commercial and Strategy Officer

  March 2, 2026

   · 

  5 min read
• Press Releases

  Nautilus Biotechnology Appoints Proteomics Commercial Leader Amber Faust as Vice President of Sales

  March 2, 2026

   · 

  6 min read
• Press Releases

  Belite Bio to Participate in the Leerink Global Healthcare Conference

  March 2, 2026

   · 

  1 min read
• Press Releases

  Effects of Icosapent Ethyl on Risk and Duration of Hospitalizations and Death in REDUCE-IT® Post Hoc Analysis Published in the European Journal of Preventive Cardiology

  March 2, 2026

   · 

  14 min read
• Press Releases

  Alnylam Receives Positive Recommendation From Canada’s Drug Agency (CDA) for the Public Reimbursement of AMVUTTRA® (vutrisiran injection), the First and Only RNAi Therapeutic for the Treatment of Cardiomyopathy in Adult Patients with ATTR Amyloidosis

  March 2, 2026

   · 

  6 min read
• Press Releases

  CNS Pharmaceuticals Appoints Lynne Kelley, MD, FACS, as Chief Medical Officer, Completing Executive Leadership Team

  March 2, 2026

   · 

  5 min read
• Press Releases

  Xsensio SA Raises $7M Oversubscribed Series A, Accelerates Clinical Deployment of Continuous Biosensing

  March 2, 2026

   · 

  2 min read
• Press Releases

  Collegium to Participate in Upcoming March 2026 Investor Conferences

  March 2, 2026

   · 

  1 min read
• Press Releases

  Xilio Therapeutics to Present at the Leerink Partners Global Healthcare Conference

  March 2, 2026

   · 

  1 min read